𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients

✍ Scribed by Luigi E. Adinolfi; Diego Ingrosso; Giuseppe Cesaro; Amelia Cimmino; Maria D'Antò; Rosanna Capasso; Vincenzo Zappia; Giuseppe Ruggiero

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
137 KB
Volume
41
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Steatosis and progression of fibrosis in
Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection
✍ Ponni Perumalswami; David E. Kleiner; Glen Lutchman; Theo Heller; Brian Borg; Yo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

Hepatic steatosis is common in patients with chronic hepatitis C (CHC) and is reported to be a risk factor for progression of fibrosis. The aims of this study were to evaluate the interactions between hepatic steatosis and fibrosis in a well-defined cohort of patients with CHC. The computerized path

Impact of patatin-like phospholipase-3 (
Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C
✍ Eric Trépo; Pierre Pradat; Andrej Potthoff; Yukihide Momozawa; Eric Quertinmont; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

Only 20% of patients with chronic hepatitis C (CHC) will develop cirrhosis, and fibrosis progression remains highly unpredictable. A recent genome-wide association study identified a genetic variant in the patatin-like phospholipase-3 (PNPLA3) gene (rs738409 C>G) associated with steatosis that was f